CEL vs. EAH, VLG, ANCR, AGY, BXP, APH, SPEC, REDX, ETX, and POLB
Should you be buying Celadon Pharmaceuticals stock or one of its competitors? The main competitors of Celadon Pharmaceuticals include ECO Animal Health Group (EAH), Venture Life Group (VLG), Animalcare Group (ANCR), Allergy Therapeutics (AGY), Beximco Pharmaceuticals (BXP), Alliance Pharma (APH), INSPECS Group (SPEC), Redx Pharma (REDX), e-therapeutics (ETX), and Poolbeg Pharma (POLB). These companies are all part of the "medical" sector.
Celadon Pharmaceuticals (LON:CEL) and ECO Animal Health Group (LON:EAH) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their community ranking, analyst recommendations, valuation, profitability, media sentiment, risk, dividends, earnings and institutional ownership.
In the previous week, ECO Animal Health Group had 4 more articles in the media than Celadon Pharmaceuticals. MarketBeat recorded 4 mentions for ECO Animal Health Group and 0 mentions for Celadon Pharmaceuticals. ECO Animal Health Group's average media sentiment score of 0.38 beat Celadon Pharmaceuticals' score of 0.00 indicating that ECO Animal Health Group is being referred to more favorably in the news media.
Celadon Pharmaceuticals has a net margin of 0.00% compared to ECO Animal Health Group's net margin of -1.83%. ECO Animal Health Group's return on equity of -0.24% beat Celadon Pharmaceuticals' return on equity.
Celadon Pharmaceuticals has a beta of 0.04, indicating that its share price is 96% less volatile than the S&P 500. Comparatively, ECO Animal Health Group has a beta of 0.07, indicating that its share price is 93% less volatile than the S&P 500.
Celadon Pharmaceuticals presently has a consensus price target of GBX 222.50, suggesting a potential upside of 119.21%. Given Celadon Pharmaceuticals' higher possible upside, research analysts plainly believe Celadon Pharmaceuticals is more favorable than ECO Animal Health Group.
ECO Animal Health Group received 289 more outperform votes than Celadon Pharmaceuticals when rated by MarketBeat users. However, 100.00% of users gave Celadon Pharmaceuticals an outperform vote while only 75.71% of users gave ECO Animal Health Group an outperform vote.
5.5% of Celadon Pharmaceuticals shares are owned by institutional investors. Comparatively, 88.2% of ECO Animal Health Group shares are owned by institutional investors. 66.1% of Celadon Pharmaceuticals shares are owned by insiders. Comparatively, 16.6% of ECO Animal Health Group shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.
ECO Animal Health Group has higher revenue and earnings than Celadon Pharmaceuticals. ECO Animal Health Group is trading at a lower price-to-earnings ratio than Celadon Pharmaceuticals, indicating that it is currently the more affordable of the two stocks.
Summary
ECO Animal Health Group beats Celadon Pharmaceuticals on 10 of the 17 factors compared between the two stocks.
Get Celadon Pharmaceuticals News Delivered to You Automatically
Sign up to receive the latest news and ratings for CEL and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding CEL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Celadon Pharmaceuticals Competitors List
Related Companies and Tools
